CS
ELGX

Candriam SCA’s Endologix Inc ELGX Stock Holding History

Candriam SCA’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,000
Closed -$100K – 852
2018
Q4 		$100K Sell
14,000
-8,000
-36% -$89.1K ﹤0.01% 776
2018
Q3 		$420K Hold
22,000
– – 0.01% 730
2018
Q2 		$1.25M Hold
22,000
– – 0.02% 571
2018
Q1 		$931K Hold
22,000
– – 0.02% 611
2017
Q4 		$1.18M Hold
22,000
– – 0.02% 562
2017
Q3 		$981K Hold
22,000
– – 0.02% 568
2017
Q2 		$1.07M Hold
22,000
– – 0.02% 567
2017
Q1 		$1.59M Hold
22,000
– – 0.03% 485
2016
Q4 		$1.26M Sell
22,000
-2,700
-11% -$247K 0.03% 474
2016
Q3 		$3.16M Buy
24,700
+2,000
+9% +$256K 0.08% 276
2016
Q2 		$2.83M Buy
+22,700
New +$2.61M 0.07% 259

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Candriam SCA's ELGX Position: Q1 2019 in Review

Candriam SCA sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 14,000 shares — an estimated $100K sold.

Candriam SCA first reported a position in ELGX in Q2 2016 and held it in 11 quarters. The position peaked at $3.16M in Q3 2016. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Candriam SCA reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Candriam SCA sold 14,000 Endologix Inc shares in Q1 2019, an estimated $100K.
  • Candriam SCA first reported a position in Endologix Inc in Q2 2016 and held it in 11 quarters.
  • Candriam SCA's Endologix Inc position peaked at $3.16M in Q3 2016.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.